
Valneva’s single-dose chikungunya vaccine authorised in Brazil
Valneva has received marketing authorisation from the Brazilian Health Regulatory Agency (ANVISA) for its single-dose chikungunya vaccine, Ixchiq, for individuals aged 18 years and above. This is the first approval of a chikungunya vaccine in a country …